- Home
- KYMR vs AZTA Comparison
KYMR vs AZTA Comparison
Compare KYMR & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- AZTA
- Stock Information
- Founded
- KYMR 2015
- AZTA 1978
- Country
- KYMR United States
- AZTA United States
- Employees
- KYMR N/A
- AZTA N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- AZTA Industrial Machinery/Components
- Sector
- KYMR Health Care
- AZTA Technology
- Exchange
- KYMR Nasdaq
- AZTA Nasdaq
- Market Cap
- KYMR 2.1B
- AZTA 2.1B
- IPO Year
- KYMR 2020
- AZTA 1995
- Fundamental
- Price
- KYMR $33.45
- AZTA $36.56
- Analyst Decision
- KYMR Buy
- AZTA Buy
- Analyst Count
- KYMR 13
- AZTA 4
- Target Price
- KYMR $56.69
- AZTA $58.75
- AVG Volume (30 Days)
- KYMR 695.8K
- AZTA 630.4K
- Earning Date
- KYMR 05-01-2025
- AZTA 05-07-2025
- Dividend Yield
- KYMR N/A
- AZTA N/A
- EPS Growth
- KYMR N/A
- AZTA N/A
- EPS
- KYMR N/A
- AZTA N/A
- Revenue
- KYMR $47,072,000.00
- AZTA $662,108,000.00
- Revenue This Year
- KYMR $44.93
- AZTA N/A
- Revenue Next Year
- KYMR N/A
- AZTA $5.58
- P/E Ratio
- KYMR N/A
- AZTA N/A
- Revenue Growth
- KYMR N/A
- AZTA 5.36
- 52 Week Low
- KYMR $29.07
- AZTA $35.90
- 52 Week High
- KYMR $53.27
- AZTA $64.31
- Technical
- Relative Strength Index (RSI)
- KYMR 44.68
- AZTA 26.56
- Support Level
- KYMR $31.54
- AZTA $39.57
- Resistance Level
- KYMR $31.66
- AZTA $45.26
- Average True Range (ATR)
- KYMR 2.31
- AZTA 2.40
- MACD
- KYMR 0.37
- AZTA -0.42
- Stochastic Oscillator
- KYMR 51.20
- AZTA 5.67
Stock Price Comparison Chart: KYMR vs AZTA
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.